Exercise capacity · adult patients with an implantable cardioverter defibrillator
1 finding from 1 review
ICD, antitachycardia pacing ( · adult patients with an implantable cardioverter defibrillator
Exercise showed no clear difference in ICD, antitachycardia pacing ( compared with no exercise at the end of the intervention (moderate certainty).
1 finding from 1 review
ICD, appropriate shock ( · adult patients with an implantable cardioverter defibrillator
Exercise showed no clear difference in ICD, appropriate shock ( compared with no exercise at the end of the intervention (low certainty).
1 finding from 1 review
ICD, inappropriate shock ( · adult patients with an implantable cardioverter defibrillator
Exercise showed no clear difference in ICD, inappropriate shock ( compared with no exercise at the end of the intervention (moderate certainty).
1 finding from 1 review
Health‐related quality of life (HRQoL) · adult patients with an implantable cardioverter defibrillator
1 finding from 1 review
All‐cause mortality at 'less than 3 months' · patients with suspected or diagnosed myocardial infarction
Beta‐blockers showed no clear difference in all‐cause mortality at 'less than 3 months' compared with placebo or no intervention (high certainty).
1 finding from 1 review
MACE · patients with suspected or diagnosed myocardial infarction
It is very uncertain whether beta‐blockers changes MACE (major adverse cardiovascular event) at maximum compared with placebo or no intervention (very low certainty).
2 findings from 1 review
Quality of life at maximum · patients with suspected or diagnosed myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Angina · patients with suspected or diagnosed myocardial infarction
It is very uncertain whether beta‐blockers changes angina at maximum compared with placebo or no intervention (very low certainty).
2 findings from 1 review
Cardiovascular mortality · patients with suspected or diagnosed myocardial infarction
Beta‐blockers probably leads to lower cardiovascular mortality at maximum compared with placebo or no intervention (moderate certainty).
2 findings from 1 review
Myocardial infarction · patients with suspected or diagnosed myocardial infarction
Beta‐blockers showed no clear difference in myocardial infarction at maximum compared with placebo or no intervention (low certainty).
2 findings from 1 review
Serious adverse events at 'less than 3 months' · patients with suspected or diagnosed myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life (SF‐20 & Q‐LES‐Q) Eight weeks · patients with suspected or diagnosed myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality maximum · patients with suspected or diagnosed myocardial infarction
Beta‐blockers probably leads to lower all‐cause mortality at maximum compared with placebo or no intervention (moderate certainty).
1 finding from 1 review
Serious adverse events maximum · patients with suspected or diagnosed myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · patients with acute myocardial infarction
Lidocaine showed no clear difference in all‐cause mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
Cardiac mortality · patients with acute myocardial infarction
Lidocaine showed no clear difference in cardiac mortality compared with placebo or no intervention (low certainty).
1 finding from 1 review
Overall survival at 30 days after myocardial infarction · patients with acute myocardial infarction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Ventricular fibrillationElectrocardiogram · patients with acute myocardial infarction
Lidocaine showed no clear difference in ventricular fibrillationElectrocardiogram compared with placebo or no intervention (low certainty).
1 finding from 1 review
Adverse events (AEs; adverse drug reaction): asystole · patients with acute myocardial infarction
It is very uncertain whether lidocaine changes adverse events (AEs; adverse drug reaction): asystole compared with placebo or no intervention (very low certainty).
1 finding from 1 review